[Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies in ovarian carcinoma].
We report the case of 71-year old Caucasian woman with ovarian cancer, who developed paraneoplastic cerebellar degeneration (PCD). Pathognomonical anti Yo antibodies could be identified in serum specimens. We describe the history and clinical presentation and summarise the disease.
Holzmann
P
P
Schwerpunktspital Wädenswil.
Holy
D
D
Stillhard
G
G
Janda
M
M
Möbr
P
P
D000368:Aged; D001323:Autoantibodies / Q000097:blood*; D001324:Autoantigens; D002526:Cerebellar Diseases / Q000175:diagnosis / Q000276:immunology*; D003131:Combined Modality Therapy; D018284:Cystadenocarcinoma, Serous / Q000276:immunology* / Q000628:therapy; D004268:DNA-Binding Proteins / Q000276:immunology*; D005260:Female; D006801:Humans; D009363:Neoplasm Proteins / Q000276:immunology*; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000276:immunology; D009410:Nerve Degeneration / Q000175:diagnosis / Q000276:immunology*; D009419:Nerve Tissue Proteins; D010051:Ovarian Neoplasms / Q000276:immunology* / Q000628:therapy; D010257:Paraneoplastic Syndromes / Q000276:immunology* / Q000628:therapy
D001323:Autoantibodies; D001324:Autoantigens; C063762:CDR1 protein, human; C095184:CDR2 protein, human; D004268:DNA-Binding Proteins; D009363:Neoplasm Proteins; D009419:Nerve Tissue Proteins
Paraneoplastische zerebelläre Degeneration (PCD) mit Anti-Yo-Antikörpern bei Ovarialkarzinom.